Literature DB >> 4543439

Studies on crystal-induced chemotactic factor. I. Requirement for protein synthesis and neutral protease activity.

I Spilberg, B Mandell, R D Wochner.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4543439

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


× No keyword cloud information.
  7 in total

1.  Modulation of the inflammatory response by products released from human polymorphonuclear leukocytes during phagocytosis : Generation and inactivation of the chemotactic factor C5a.

Authors:  D G Wright; J I Gallin
Journal:  Inflammation       Date:  1975-03       Impact factor: 4.092

2.  Induction of arthritis by purified cell-derived chemotactic factor: role of chemotaxis and vascular permeability.

Authors:  I Spilberg; D Rosenberg; B Mandell
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

3.  Alteration of polymorphonuclear leukocyte surface charge by endogenous and exogenous chemotactic factors.

Authors:  T M Schaack; A Takeuchi; I Spilberg; R H Persellin
Journal:  Inflammation       Date:  1980-03       Impact factor: 4.092

4.  Urate crystal-induced chemotactic factor: isolation and partial characterization.

Authors:  I Spilbert; A Gallacher; J M Mehta; B Mandell
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

5.  Effect of tunicamycin C2 on the induction of crystal induced chemotactic factor in human neutrophils.

Authors:  A K Bhatt; I Spilberg
Journal:  Agents Actions       Date:  1988-07

6.  Bacillus Calmette-Guérin-stimulated neutrophils release chemotaxins for monocytes in rabbit pleural spaces and in vitro.

Authors:  V B Antony; S A Sahn; A C Antony; J E Repine
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

7.  Mechanism of action of colchicine in acute urate crystal-induced arthritis.

Authors:  I Spilberg; B Mandell; J Mehta; L Simchowitz; D Rosenberg
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.